repositioning comt inhibitors and response duration in levodopa optimisation – round table
Published 4 years ago • 151 plays • Length 30:22Download video MP4
Download video MP3
Similar videos
-
2:00
adjunctive mao-b or comt inhibitors to optimize levodopa treatment in pd
-
20:31
recognition and management of wearing off utilisation of comt inhibitors – oliver rascol
-
1:06
comt inhibitors for parkinson’s disease: clinical updates
-
1:18
comt inhibitors for motor fluctuations in parkinson’s disease
-
25:02
early vs late use of levodopa – angelo antonini
-
22:00
diagnosis and management of levodopa response fluctuations in parkinson’s disease – werner poewe
-
2:29
comt inhibitors for parkinson's disease
-
15:18
comt inhibitors || in parkinson disease
-
1:18
adjunctive mao-b or comt inhibitors for parkinson's disease
-
35:02
moving toward optimal management of advanced parkinson’s disease
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
5:32
new formulation of levodopa aims to serve as rescue treatment for parkinson's patients
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
3:32
adequately treating parkinson disease with levodopa
-
1:02:56
new diagnosis workshop series: parkinson's treatment
-
37:41
antiparkinson drugs pharmacology: levodopa and carbidopa, entacapone, selegiline, pramipexole & more
-
1:15:55
michigan parkinson foundation - lwp - session 2, managing medications - oct 22, 2020